Budget Impact of Publicly Reimbursed Prescription Medicines in the Republic of Srpska
نویسندگان
چکیده
Health Care Services in the Republic of Srpska are provided through the primary, secondary, and tertiary care levels. Primary medical services provision happens throughout the network of 53 primary health care facilities and 1 family medicine polyclinic (1). There are approximately 500 pharmacies (2). Secondary and tertiary health care services are provided in two university hospitals, nine regional hospitals, three health centers, two specialized psychiatric clinics, and two specialized medical rehabilitation facilities (3). Insured citizens use health care services in public health care institutions and private institutions who have signed the contract with the Health Insurance Fund. Health care financing is mostly provided by the Health Insurance Fund, out of the mandatory taxes imposed to the employers and employees alike. Coverage for unemployed population is extended from the employed family member premiums (4). Fund is a legal entity established and owned by the State (5). The Ministry of Health and Social Welfare conducts the supervision of the Fund (6). One of the main functions of the Health Insurance Fund is collection of contributions for health insurance and contracting of health services. Complementary direct payment of contributions is made to the Pension and Disability Insurance Fund (7). The health care system in the Republic of Srpska is centralized with the overall power trusted to the Ministry of Health and Social Welfare, the Institute of Public Health, and the Health Insurance Fund. Employee pool in the health care system of the Republic of Srpska consists of approximately 2,400 clinical physicians, 200 dentists, 100 pharmacists, 6,500 nursing staff, and 4,000 administrative and technical staff (1). Gross National Income per capita increased from 8,770 to 9,820 US$ during 2009–2013 span. Total expenditure on health, as a percentage of gross domestic product, was 9.9% in 2012 (last official release) (8). The Republic of Srpska has around a population of 1,327,000 (9), and health expenditure per capita in 2009 amounted toAC389while in 2013 it reachedAC397 (10). Private and public expenditure on health care has increased in total from 2009 to 2012, and the public share of spending grew from 68.81 to 70.33% (11).
منابع مشابه
Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future.
The prescribing of medicines is a fundamental component of care for the elderly; however, there is increasing concern with polypharmacy and its impact on morbidity, mortality and costs. As a result, long-term prescription-medicine use and the prevalence of polypharmacy in the elderly in the Republic of Srpska were analyzed. The findings were subsequently used to suggest potential future measure...
متن کاملImpact of delisting OTC medicines from reimbursement list
Objectives This analysis aims at determining how many OTCs were reimbursed before the exclusion and how many of them and under what conditions of reimbursement remained to be reimbursed. The second objective of the analysis is to estimate the financial effect of exclusion on the payers and patients. The third objective is to describe what type of OTCs are reimbursed and under what conditions of...
متن کاملLong-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina.
BACKGROUND/AIM Prescription of drugs is a fundamental care component of the elderly. Elderly patients often take multiple drugs, and it is known that polypharmacy may lead to drug interactions and adverse events. The aim of this study was to analyze the long-term drug use and the prevalence of polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina. METHODS; ...
متن کاملHow much do we spend on prescription medicines? Out-of-pocket costs for patients in Australia and other OECD countries.
OBJECTIVES To determine changes in out-of-pocket expenditure on prescription medicines for Australian patients, and how patient expenditure compares with other Organisation for Economic Co-operation and Development (OECD) countries. METHODS We examined out-of-pocket expenditure on prescription medicines by patients in Australia between 1970 and 2007, and between Australia and 15 other OECD co...
متن کاملParticipation in pharmaceutical costs and seniors' access to medicines in the Czech Republic.
OBJECTIVES Analysis of participation in drug costs by seniors in the Czech Republic in connection with seniors' access to pharmacotherapy. MATERIALS AND METHODS Quota-sampled guided interview with 450 respondents visiting pharmacy; ratio of men and women approximately 1:2; age over 60 years; 3 regions of the Czech Republic. RESULTS Respondent's income was retirement pension in 80%. More tha...
متن کامل